已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

What is the optimal duration of neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC)?: a real-world study

化学免疫疗法 医学 新辅助治疗 内科学 优势比 肿瘤科 逻辑回归 阶段(地层学) 比例危险模型 置信区间 肺癌 多元分析 腺癌 癌症 外科 免疫疗法 古生物学 乳腺癌 生物
作者
Zhoujunyi Tian,Haoshuai Yang,Jin Zhang,Deruo Liu,Chaoyang Liang,Zhenrong Zhang
出处
期刊:European Journal of Cardio-Thoracic Surgery [Oxford University Press]
卷期号:67 (7) 被引量:1
标识
DOI:10.1093/ejcts/ezaf218
摘要

OBJECTIVES: The optimal duration of neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer remains unknown. This study aimed to assess whether the number of cycles of neoadjuvant therapy affects oncologic efficacy and surgical safety in a real-world setting. METHODS: Patients with resectable non-small cell lung cancer who received neoadjuvant chemoimmunotherapy and subsequent surgery were included. Patients were divided into 2 groups: ≤2 or >2 cycles. Oncology outcomes such as pathological complete response (pCR) and surgical outcomes were compared. Binary logistic regression analyses were conducted to identify independent factors for pCR. Kaplan-Meier analysis was used to compare long-term survival between groups. Cox regression analyses were conducted to identify independent predictors of recurrence. RESULTS: A total of 140 patients with clinical stage IB-IIIB disease were included; 68 received ≤2 cycles and 72 received >2 cycles of neoadjuvant chemoimmunotherapy. No significant differences between groups were observed in pCR rates, surgery difficulty, and postoperative complications. Multivariate binary logistic regression analysis indicated that adenocarcinoma [odds ratio 0.14, 95% confidence interval 0.04-0.50, P = .003] and clinical T3 stage (odds ratio 0.18, 95% confidence interval 0.05-0.72, P = .015) were unfavourable factors for pCR. Kaplan-Meier survival analysis revealed no significant difference in recurrence-free survival or overall survival between groups. Multivariate Cox regression analysis revealed that the number of neoadjuvant cycles was not a predictor of recurrence (hazard ratio 0.87, 95% confidence interval 0.31-2.44, P = .8). CONCLUSIONS: Compared with 3 or more cycles, 2 cycles of neoadjuvant chemoimmunotherapy might achieve similar perioperative outcomes and long-term survival in selected patients. Prospective studies and extended follow-up are needed to verify the conclusions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李爱国的应助被沉静朋友采纳,获得10
2秒前
搜集达人的应助被互化化采纳,获得30
5秒前
扶摇完成签到,获得积分10
6秒前
6秒前
领导范儿的应助被科研通管家采纳,获得10
8秒前
斯文败类的应助被科研通管家采纳,获得10
8秒前
8秒前
Akim的应助被科研通管家采纳,获得10
8秒前
molihuakai的应助被科研通管家采纳,获得10
8秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
8秒前
Orange的应助被科研通管家采纳,获得10
8秒前
Owen的应助被科研通管家采纳,获得10
8秒前
无极微光的应助被科研通管家采纳,获得20
9秒前
天天快乐的应助被科研通管家采纳,获得10
9秒前
JamesPei的应助被Suc采纳,获得10
9秒前
9秒前
汉堡包的应助被科研通管家采纳,获得10
9秒前
打打的应助被科研通管家采纳,获得10
9秒前
molihuakai的应助被科研通管家采纳,获得10
9秒前
9秒前
科目三的应助被科研通管家采纳,获得10
9秒前
田様的应助被花音采纳,获得10
10秒前
传奇3的应助被拉登是我干掉的采纳,获得10
11秒前
晚晚发布了新的文献求助10
12秒前
樊新竹完成签到,获得积分10
14秒前
14秒前
David梁生完成签到 ,获得积分10
14秒前
xiaolizi的应助被沭阳检验医师采纳,获得100
15秒前
欧阳完成签到 ,获得积分10
15秒前
xixilulixiu完成签到 ,获得积分10
17秒前
18秒前
18秒前
简单项链发布了新的文献求助10
19秒前
21秒前
互化化发布了新的文献求助30
22秒前
柏白凝发布了新的文献求助10
23秒前
25秒前
25秒前
充电宝的应助被Quanquan采纳,获得30
26秒前
简单项链完成签到,获得积分10
30秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Composite Materials Handbook Volume 1 - Revision H 1000
Composite Materials Handbook Volume 3 - Revision H 1000
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7806206
求助须知:如何正确求助?哪些是违规求助? 9339358
关于积分的说明 20496567
捐赠科研通 7398236
什么是DOI,文献DOI怎么找? 3328021
关于科研通互助平台的介绍 2474757
邀请新用户注册赠送积分活动 2346147